This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignees: B. Braun Surgical S.a., Fundacio Institut De Ciencies Fotoniques, Institucio Catalana De Recerca I Estudis Avancats. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 8 
1 out of 55 
1 out of 93 
Years Active: 2019
Title: Innovative Contributions of Christine Weis in Bacteriostatic Technology
Introduction
Christine Weis, an accomplished inventor based in Rubi, Spain, has made significant strides in the field of bacteriostatic technology. With one patent to her name, she has demonstrated a profound understanding of materials science and microbiology, particularly in developing surfaces with advanced antibacterial properties.
Latest Patents
Christine Weis holds a patent for a revolutionary invention titled "Modified surface capable of having bacteriostatic and bactericidal activity, the method for obtaining it and use thereof." This innovative technology involves a modified surface that exhibits bacteriostatic and bactericidal activity upon light irradiation. The surface can prevent microorganisms from attaching, inhibit biofilm formation, and eliminate existing biofilms, offering a solution that remains effective for an indefinite period, provided it is exposed to light.
Career Highlights
Throughout her career, Christine has worked with notable institutions, including B. Braun Surgical S.A. and Fundació Institut de Ciències Fotòniques. Her dedication to research and innovation has led to breakthroughs that have potential applications in various fields, especially in healthcare settings where infection control is critical.
Collaborations
Christine Weis has collaborated with esteemed colleagues such as Romain Quidant and Susana Santos. These partnerships highlight her capability to work effectively within teams, contributing to the advancement of technology through shared expertise and innovative ideas.
Conclusion
Christine Weis continues to pave the way for advancements in bacteriostatic technologies, offering promising solutions for infection control and biofilm prevention. With her patent, she demonstrates the potential for innovation that can have lasting impacts across multiple industries. Her contributions serve as an inspiration for future inventors aiming to create effective solutions for pressing global challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile